Aequus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is C$-0.02; its P/E ratio is ―; Aequus Pharmaceuticals is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Income Statement	-
Total Revenue	$ 148.32K	$ 161.41K	$ 52.55K	$ 50.88K	$ 13.36K
Gross Profit	$ 75.44K	$ 74.85K	$ 34.96K	$ 35.57K	$ 2.90K
EBIT	$ -614.73K	$ -683.03K	$ -609.75K	$ -668.23K	$ -767.87K
EBITDA	$ -581.65K	$ -649.95K	$ -576.67K	$ -634.31K	$ -733.12K
Net Income Common Stockholders	$ -614.73K	$ -683.03K	$ -662.09K	$ -715.87K	$ -803.65K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 70.26K	$ 88.93K	$ 286.89K	$ 215.05K	$ 156.87K
Total Assets	$ 858.02K	$ 1.01M	$ 1.09M	$ 1.09M	$ 1.86M
Total Debt	$ 612.23K	$ 639.93K	$ 667.16K	$ 693.78K	$ 717.49K
Net Debt	$ 541.98K	$ 551.00K	$ 380.26K	$ 478.73K	$ 560.62K
Total Liabilities	$ 7.08M	$ 6.62M	$ 6.04M	$ 5.38M	$ 4.76M
Stockholders Equity	$ -6.22M	$ -5.61M	$ -4.95M	$ -4.29M	$ -3.59M
Cash Flow	-
Free Cash Flow	$ -348.70K	$ -706.10K	$ -521.70K	$ -902.11K	$ -649.73K
Operating Cash Flow	$ -348.70K	$ -706.10K	$ -521.70K	$ -902.11K	$ -649.73K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ 330.02K	$ 508.14K	$ 593.55K	$ 960.29K	$ 731.36K

Currency in USD

Aequus Pharmaceuticals Earnings and Revenue History

Income Statement >

Aequus Pharmaceuticals Debt to Assets

Balance Sheet >

Aequus Pharmaceuticals Cash Flow

Cash Flow >

Aequus Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing